Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.

Clicks: 409
ID: 44661
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #204 of 2,056 articles by views in PloS one

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 2,056 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Management of the Primary Membranous Nephropathy (PMN) usually involves administration of immunosuppressives. Cyclophosphamide (Cyclo) and Calcineurin Inhibitors (CNIs) are both widely used but only limited data exist to compare their efficacy in long term follow-up.The aim of the present study was to estimate and compare long term effects of Cyclo and CNIs in patients with PMN.Clinical data, histologic findings and long term outcome were retrospectively studied. The response to treatment and rate of relapse was compared between patients treated with CNIs or Cyclo based immunosuppressive regimens.Twenty three centers participated in the study, with 752 PMN patients (Mean age 53.4(14-87) yrs, M/F 467/285), followed for 10.1±5.7 years. All patients were initially treated with Renin Angiotensin Aldosterone System inhibitors (RAASi) for at least 6 months. Based on their response and tolerance to initial treatment, patients were divided into 3 groups, group I with spontaneous remission, who had no further treatment, group II, continued on RAASi only, and group III on RAASi+immunosuppression. Immunosuppressive regimes were mainly based on CNIs or Cyclo. Frequent relapses and failure to treatment were more common between patients who had started on CNIs (n = 381) compared to those initially treated with Cyclo (n = 110), relapse rate: 25.2% vs. 6.4%, p<0.0001, and no response rate: 22.5% vs. 13.6%, p = 0.04, respectively.Long term follow up showed that administration of Cyclo in PMN is followed by better preservation of renal function, increased response rate and less frequent relapses, compared to CNIs.
Reference Key
stangou2019immunosuppressiveplos Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Stangou, Maria;Marinaki, Smaragdi;Papachristou, Evangelos;Kolovou, Kyriaki;Sambani, Erasmia;Zerbala, Synodi;Papadea, Panagiota;Balafa, Olga;Rapsomanikis, Karolos-Pavlos;Andrikos, Aimilios;Manolakaki, Panagiota;Papadopoulou, Dorothea;Mitsopoulos, Efstathios;Liakou, Helen;Andronikidi, Paraskevi-Evi;Choulitoudi, Vasiliki;Moustakas, George;Galitsiou, Dimitra;Dafnis, Eugene;Stylianou, Kostas;Stefanidis, Ioannis;Golfinopoulos, Spyridon;Panagoutsos, Stylianos;Tsilivigkou, Maria;Papadogianakis, Apostolos;Tzanakis, Ioannis;Sioulis, Athanasios;Vlachakos, Dimitrios;Grapsa, Eirini;Spaia, Sophia;Kaperonis, Nikolaos;Paliouras, Christos;Dioudis, Christos;Papoulidou, Fani;Apostolou, Theofanis;Iatrou, Christos;Boletis, Ioannis;Goumenos, Dimitrios;Papagianni, Aikaperini;
Journal PloS one
Year 2019
DOI
10.1371/journal.pone.0217116
URL
Keywords
speech-language pathology voice voice training drama laryngology speech acoustics vocal cords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.